Andrew C. Jackson insider trades
Open-market stock purchases and sales by Andrew C. Jackson, Chief Financial Officer at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Jun 13, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc | Bought (not open market) | $19K |